About GSK
GSK is a company based in Brentford (United Kingdom) founded in 1715 was acquired by Unilever in December 2018. The company has 68,630 employees as of December 31, 2024. GSK has completed 25 acquisitions, including 35Pharma, Affinivax and Aiolos Bio. GSK operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Brentford, United Kingdom
- Employees 68630 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gsk Plc
-
Annual Revenue
$39.32 B (USD)3.46as on Dec 31, 2024
-
Net Profit
$3.23 B (USD)-47.75as on Dec 31, 2024
-
EBITDA
$10.29 B (USD)-11.56as on Dec 31, 2024
-
Latest Funding Round
$415.25 K (USD), Grant
Dec 29, 2023
-
Investors
Unilever
& 9 more
-
Employee Count
68630
as on Dec 31, 2024
-
Investments & Acquisitions
35Pharma
& 24 more
-
Acquired by
Unilever
(Dec 03, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of GSK
GSK is a publicly listed company on the LSE with ticker symbol GSK in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of GSK
Unlock access to complete
Unlock access to complete
Software Development Team
259 people
Leadership Team
231 people
Product Management Team
99 people
Data Analysis and Operations Team
47 people
Senior Team
41 people
Operations Team
40 people
Human Resources and Administration
32 people
Finance and Accounting
24 people
Unlock access to complete
Funding Insights of GSK
Investors in GSK
GSK has secured backing from 10 investors, including institutional investors. Prominent investors backing the company include Unilever, Elliott Management and Scottish Enterprise.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Activist investing in undervalued European public equities through engagement.
|
Locked | Locked | Locked |
Investor details for GSK
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GSK
GSK has strategically engaged in corporate development activities, having acquired 25 companies. Notable acquisitions include 35Pharma, Affinivax and Aiolos Bio.
Investment portfolio details for GSK
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions
|
Locked | Locked | 2023 | Locked | |
|
Precision combination therapies for cancer drivers are developed by IDRx.
|
Locked | Locked | 2022 | Locked | |
|
Designs and develops innovative biologics for unmet medical needs in healthcare.
|
Locked | Locked | 2021 | Locked |
Complete acquisition details for GSK
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - GSK
Detailed financials for GSK
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gsk Comparisons
Peer comparison for GSK
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GSK
GSK operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of GSK
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gsk
Complete news archive for GSK
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GSK
GSK was founded in 1715 and raised its 1st funding round 293 years after it was founded.
GSK is headquartered in Brentford, United Kingdom. It is registered at Brentford, England, United Kingdom.
Dame Emma Walmsley is the current CEO of GSK.
As of Dec 31, 2024, the latest employee count at GSK is 68,630.
Annual revenue of GSK is $39.32B as on Dec 31, 2024.
Founded in 1715, GSK operates in the pharmaceutical sector, with a focus on research, development, clinical trials, and commercialization of medicines and vaccines. Treatments are provided for respiratory, immunology, inflammatory, oncology, HIV, and infectious diseases. Global access to products is emphasized, alongside sustainable practices, from its base in Brentford, United Kingdom.
GSK's top competitors include Merck, Roivant Sciences and AbbVie.
Yes, GSK is publicly traded on LSE under the ticker symbol GSK.
GSK has made 25 acquisitions, including 35Pharma, Affinivax, and Aiolos Bio.
GSK has 10 investors. Key investors include Unilever, Elliott Management, Scottish Enterprise, CARB-X, and European Union.
The ticker symbol of GSK is GSK on LSE.